This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Plasma Protein System Market

Market Insights on Plasma Protein System covering sales outlook, demand forecast & up-to-date key trends

Plasma Protein System Market By Product Type (Fibrinogen, Immunoglobulin, Albumin), Application (Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, Hemophilia), End User (Blood Banks, Ambulatory Surgical Centers, Clinics, Hospitals) & Region - Forecast 2022-2032

Plasma Protein System Market Overview

The global plasma protein system market size is expected to reach US$ 25.7 Billion in 2022 and US$ 28.4 Billion in 2032. It is anticipated to exhibit growth at a steady CAGR of 6.2% in the forecast period from 2022 to 2032. The increasing demand for innovative therapeutic options and the surging approval of several plasma products worldwide are set to propel the sales of plasma protein systems.

Report Attribute

Details

Plasma Protein System Market Estimated Base Year Value (2021)

US$ 24.1 Billion

Plasma Protein System Market Expected Market Value (2022)

US$ 25.7 Billion

Plasma Protein System Market Anticipated Forecast Value (2032)

US$ 28.4 Billion

Plasma Protein System Market Projected Growth Rate (2022-2032)

6.2% CAGR

Plasma protein, also known as blood protein, is a type of protein that is present in blood plasma. It serves various functions, such as the transportation of minerals, vitamins, hormones, and lipids in the body to maintain one’s immune system. It also acts as a kinin precursor, complement component, and an enzyme.

The rising usage of plasma proteins in replacement therapies to treat several conditions, including the deficiency of a coagulation factor during hemostasis is expected to propel the market. The increasing focus of many key players on the development of new systems that have enhanced efficacy is another crucial factor that is set to accelerate the market.

The ongoing development of innovative plasma extraction techniques and the surging prevalence of neuropathic pain and post-polio syndrome are anticipated to spur the demand for plasma protein systems. The rising demand for albumin in Asia Pacific for the treatment of sepsis, liver disease, Alzheimer’s disease, and malaria is also likely to drive the market.

Which are Some Prominent Drivers Spearheading Plasma Protein System Market Growth?

High life expectancy and improved standard of living are expected to drive the geriatric population across the globe. It is further anticipated to result in favorable reimbursement policies and technological advancements in the healthcare sector.

The increasing prevalence of neurological and cardiovascular disorders among the geriatric population is likely to augur well for the global plasma protein system market growth in the evaluation period. According to the Pan American Health Organization (PAHO), around 533,172 deaths occurred in 2019 in the Region of the Americas due to neurological conditions. This number is projected to grow in the near future, thereby boosting the global market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Plasma Protein System Industry?

The lack of favorable reimbursement policies, especially in emerging economies is anticipated to hamper the growth in this market. In addition to that, the implementation of stringent norms by government bodies to control the handling of plasma protein products is expected to obstruct the growth. Plasma protein fractions can also lead to numerous side effects, such as hives, low blood pressure, fever, pulmonary edema, and anaphylaxis. This factor may hinder the growth in this market.

Why is North America emerging as an Opportunistic Plasma Protein System Market?

North America is estimated to remain at the forefront by generating the largest plasma protein system market share in the future years. This growth is attributable to the availability of a well-established infrastructure to maintain and store premium-quality plasma in the U.S.

Besides, the rising adoption of cutting-edge therapeutics and the presence of a large patient base in the U.S. are some of the other factors that are set to fuel the market. The increasing prevalence of numerous life-threatening diseases and the surging geriatric population are also projected to bode well for the North America market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Asia Pacific Contributing to Growth of the Plasma Protein System Market?

Asia Pacific is likely to showcase the fastest CAGR in the assessment period owing to the increasing usage of albumin in China. The rising per capita income of people and the growing need for state-of-the-art treatment options in India are estimated to bolster the demand for plasma protein systems across Asia Pacific.

As per a research study published by the National Library of Medicine, since 2006, the prevalence of cardiovascular diseases has increased at a fast pace in China. Out of about 290 million patients with these diseases, 245 million, 13 million, and 4.5 million have hypertension, stroke, and heart failure, respectively. Thus, the surging prevalence of various diseases in developing countries of Asia Pacific is projected to drive the market. 

Market Competition

Some of the renowned companies operating in the global plasma protein system market are Octapharma USA Inc., CSL Behring, Takeda Pharmaceutical Company Ltd., Grifols SA, Baxter, Biotest AG, and China Biologic Products, Inc. among others.

Majority of the key players are engaging in research and development activities to come up with novel products to gain fast track approvals from regulatory bodies. The market is highly competitive with the presence of many large- and small-scale companies that are increasingly focusing on broadening their plasma collection networks. Meanwhile, a few other companies are aiming to surge their market share by conducting clinical trials and expanding their geographic presence.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 6.2% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Application
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Easter Europe
  • APEJ
  • Japan
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Octapharma USA Inc.
  • CSL Behring
  • Takeda Pharmaceutical Company Ltd.
  • Grifols SA
  • Baxter
  • Biotest AG
  • China Biologic Products, Inc.

Customization

Available Upon Request

Key Segments Profiled in the Plasma Protein System Industry Survey

By Product Type:

  • Fibrinogen
  • Immunoglobulin
  • Albumin

By Application:

  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Primary Immunodeficiency Disorder (PID)
  • Hemophilia
  • Others

By End User:

  • Blood Banks
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals

By Region:

  • North America
  • Latin America
  • Western Europe
  • Easter Europe
  • APEJ
  • Japan
  • Middle East & Africa

Frequently Asked Questions

The global plasma protein system market is estimated to surpass US$ 28.4 Billion till 2032.

North America is likely to dominate the plasma protein system market.

Octapharma USA Inc., CSL Behring, Takeda Pharmaceutical Company Ltd., Grifols SA, Baxter, Biotest AG, and China Biologic Products, Inc. are some of the leading plasma protein system manufacturers.

Table of Content

N/A

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Plasma Protein System Market